Evidence map›Paper›PMID 27035990›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Rethinking progesterone regulation of female reproductive cyclicity.

Kaiyu Kubota, Wei Cui, Pramod Dhakal, Michael W Wolfe, M A Karim Rumi, Jay L Vivian, Katherine F Roby, Michael J Soares

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Methods for Defining the Role of ADAMTS1 in the Ovary.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Metalloproteases in gonad formation and ovulation.General and comparative endocrinology · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Protective role of IL33 signaling in negative pregnancy outcomes associated with lipopolysaccharide exposure.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kaiyu KubotaInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160; msoares@kumc.edu kkubota@kumc.edu.
Wei CuiInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160;
Pramod DhakalInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160;
Michael W WolfeInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160;
M A Karim RumiInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160;
Jay L VivianInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160;
Katherine F RobyInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160;
Michael J SoaresInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS 66160 msoares@kumc.edu kkubota@kumc.edu.
University of Kansas Medical Center · USInstitute for Reproductive Health · US

Funding

Dissecting Uterine Progesterone ResistanceR21HD066406 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SOARES, MICHAEL J · 2012 to 2013
$404k
Rat Models for Sex Steroid ActionR21OD010478 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SOARES, MICHAEL J · 2013 to 2014
$395k
NICHD NIH HHS R21 HD066406NIH HHS R21 OD010478
6 · The paper itself

Abstract

The progesterone receptor (PGR) is a ligand-activated transcription factor with key roles in the regulation of female fertility. Much has been learned of the actions of PGR signaling through the use of pharmacologic inhibitors and genetic manipulation, using mouse mutagenesis. Characterization of rats with a null mutation at the Pgr locus has forced a reexamination of the role of progesterone in the regulation of the female reproductive cycle. We generated two Pgr mutant rat models, using genome editing. In both cases, deletions yielded a null mutation resulting from a nonsense frame-shift and the emergence of a stop codon. Similar to Pgr null mice, Pgr null rats were infertile because of deficits in sexual behavior, ovulation, and uterine endometrial differentiation. However, in contrast to the reported phenotype of female mice with disruptions in Pgr signaling, Pgr null female rats exhibit robust estrous cycles. Cyclic changes in vaginal cytology, uterine histology, serum hormone levels, and wheel running activity were evident in Pgr null female rats, similar to wild-type controls. Furthermore, exogenous progesterone treatment inhibited estrous cycles in wild-type female rats but not in Pgr-null female rats. As previously reported, pharmacologic antagonism supports a role for PGR signaling in the regulation of the ovulatory gonadotropin surge, a result at variance with experimentation using genetic ablation of PGR signaling. To conclude, our findings in the Pgr null rat challenge current assumptions and prompt a reevaluation of the hormonal control of reproductive cyclicity.

Indexed as

AnimalsExonsFemaleLuteinizing HormoneMifepristoneMutationProgesteroneRatsReproductionLuteinizing HormoneMifepristoneProgesteronePGRprogesteroneratreproductive cycles

Identifiers

PMID27035990
PMCPMC4839436
OpenAlexW2316473644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.